In line with this, we observed a strong trend toward decreased levels of the inactive p-Ser9 GSK-3β in the SN of GS mice, without changes in total GSK-3β.
← all excerpts
The G2019S LRRK2 mutation exacerbates α-synuclein and tau neuropathology through divergent pathways in Parkinson's disease models.
1
—
—